Open AccessTreatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea
Author(s) -
K. S. Lee,
InChang Cho,
Jae-Young Joung,
Ho Kyung Seo,
Jinsoo Chung,
Weon Seo Park
Publication year - 2014
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.136546
Subject(s) - docetaxel , medicine , prostate cancer , hazard ratio , prednisolone , chemotherapy , regimen , oncology , prostate specific antigen , cancer , chemotherapy regimen , surgery , confidence interval
We retrospectively reviewed the treatment outcomes of docetaxel plus prednisolone chemotherapy in Korean men with metastatic castration-resistant prostate cancer (mCRPC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom